About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
Technology
Technology Platforms
Chroma ™
Sofra ™
mRNA Vaccines
Autoimmune Disease
Veyonda ®
Clinical Trials
IONIC
Other Trials
DARRT
CEP
LuPIN
NOXCOVID
Publications
Investor Centre
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Publications
Publications
Publications
Filter by Year:
2022
2020
2019
2018
2017
20-Nov-2017
NOX66 Plus Carboplatin - Phase 1 Signalling Study
13-Nov-2017
Trial Design: Safety of NOX66 in Combination with Palliative Dose Radiotherapy - A Phase 1 Dose Escalation Study
13-Nov-2017
Idronoxil levels of patients receiving NOX66
13-Nov-2017
ENOX2 levels of patients receiving NOX66
11-Sep-2017
Chemosensitization of Carboplatin by NOX66
1
